Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.27 | 1.01 | 0.99997 | 1.00000 | |
RegionR2 | 5.634 | 1.01 | 0.09968 | 0.38798 | |
RegionR3 | -0.485 | 1.01 | 0.99971 | 1.00000 | |
RegionR4 | -1.732 | 1.01 | 0.99985 | 1.00000 | |
RegionR5 | -0.962 | 1.01 | 0.99993 | 1.00000 | |
RegionR6 | -0.828 | 1.01 | 1.00000 | 1.00000 | |
RegionR7 | -0.376 | 1.01 | 0.99987 | 1.00000 | |
RegionR8 | 0.021 | 1.01 | 0.99986 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.262 | 1.01 | 0.99987 | 1.00000 | |
RegenerationR2 | -0.555 | 1.01 | 0.68399 | 0.95022 | |
RegenerationR3 | 2.594 | 1.01 | 0.42000 | 0.81507 | |
RegenerationR4 | -0.124 | 1.01 | 1.00000 | 1.00000 | |
RegenerationR5 | -0.32 | 1.01 | 0.99986 | 1.00000 | |
RegenerationR6 | 1.155 | 1.01 | 0.44777 | 0.76875 | |
RegenerationBL | -0.926 | 1.01 | 0.99993 | 1.00000 | |
RegenerationTP | -0.527 | 1.01 | 0.99985 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_19578 | 23 | 0.47 | Mlig455_018093, Mlig455_059526 | Neo: - Age: - |
3 | - | - | 1.000 | 1.000 | 1.000 | - | Mlig455_018093 {REF} {Length: 2450} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=99.2]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=72.4, Expect=4e-13]} {RNA1310_65251} Mlig455_059526 {REF} {Length: 2621} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Smed: dd_Smed_v6_21491_0_1, dd_Smed_v6_21491_0_1, [Score=74.7, Expect=8e-14]} {RNA1310_65251} |
|
2. | MligTC455_53468 | 14 | 0.28 | Mlig455_070377 | Neo: - Age: - |
2.752 | - | - | 0.999 | 0.992 | 0.761 | - | Mlig455_070377 {REF} {Length: 2927} {Pfam: Glycine rich protein [PF12810.9, score=23.6]} {RNA1509_10020} {RNA1310_33363.2} {RNA815_25152} | |
3. | MligTC455_43889 | 8 | 0.16 | Mlig455_042755 | Neo: - |
GRM8 | 2.737 | - | - | 0.875 | 0.964 | 0.898 | - | Mlig455_042755 {REF} {Length: 4300} {Pfam: Receptor family ligand binding region [PF01094.30, score=260.1]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=174.7]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=45.9]; Periplasmic binding protein [PF13458.8, score=31.1]} {Human: ENSG00000179603, GRM8, glutamate metabotropic receptor 8, [RH, Score=714, Expect=0.0]; ENSG00000196277, GRM7, glutamate metabotropic receptor 7, [RH, Score=709, Expect=0.0]; ENSG00000124493, GRM4, glutamate metabotropic receptor 4, [RH, Score=683, Expect=0.0]} {Mouse: ENSMUSG00000024211, Grm8, glutamate receptor, metabotropic 8, [RH, Score=711, Expect=0.0]; ENSMUSG00000056755, Grm7, glutamate receptor, metabotropic 7, [RH, Score=707, Expect=0.0]; ENSMUSG00000063239, Grm4, glutamate receptor, metabotropic 4, [RH, Score=694, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=652, Expect=0.0]} {Celegans: WBGene00021152, mgl-3, Metabotropic GLutamate receptor family, [RH, Score=622, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=600, Expect=0.0]} {RNA1310_30380} {RNA815_34532} |
4. | MligTC455_17947 | 64 | 1.34 | Mlig455_042563 | Neo: - Age: - Region-enriched R2: 7.054/0.00113 |
ASCL5 | 2.733 | - | - | 0.935 | 0.848 | 0.950 | - | Mlig455_042563 {REF} {Length: 1821} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=52.5]} {Human: ENSG00000232237, ASCL5, achaete-scute family bHLH transcription factor 5, [Score=84.7, Expect=6e-20]} {Mouse: ENSMUSG00000097918, Ascl5, achaete-scute family bHLH transcription factor 5, [Score=84.0, Expect=5e-20]} {Dmel: FBgn0002922, nau, nautilus, [Score=49.3, Expect=6e-07]} {Celegans: WBGene00001952, hlh-6, Helix-loop-helix protein 6, [RH, Score=90.9, Expect=4e-22]} {Smed: dd_Smed_v6_14753_0_1, dd_Smed_v6_14753_0_1, [RH, Score=76.6, Expect=2e-17]} {RNA1310_71187} |
5. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
2.704 | - | - | 0.863 | 0.877 | 0.964 | - | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
6. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
2.692 | - | - | 0.959 | 0.771 | 0.962 | - | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
7. | MligTC455_19304 | 36 | 0.76 | Mlig455_036451 | Neo: - Age: - |
2.671 | - | - | 0.888 | 0.987 | 0.796 | - | Mlig455_036451 {REF} {Length: 1603} {Smed: dd_Smed_v6_16261_0_1, dd_Smed_v6_16261_0_1, [RH, Score=266, Expect=8e-87]} {RNA1310_117429} | |
8. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 2.668 | - | - | 0.984 | 0.939 | 0.745 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
9. | MligTC455_50844 | 224 | 4.67 | Mlig455_018511 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.591/0.00005 |
SSUH2 | 2.665 | - | - | 0.953 | 0.848 | 0.864 | - | Mlig455_018511 {REF} {Length: 1843} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=120, Expect=2e-29]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=95.5, Expect=3e-21]} {RNA1509_39980} {RNA1310_60742, RNA1509_39980} {RNA1509_39980, RNA815_28938} |
10. | MligTC455_45020 | 386 | 8.05 | Mlig455_012422 | Neo: - Age: - Region-enriched R2: 4.067/0.00066 |
AVP | 2.653 | - | - | 0.952 | 0.813 | 0.888 | - | Mlig455_012422 {REF} {Length: 1252} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.0]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=50.4, Expect=4e-08]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=52.0, Expect=7e-09]} {RNA1509_50574} {RNA1310_26737, RNA1509_50574} {RNA1509_50574, RNA815_23813} |
11. | MligTC455_37270 | 86 | 1.79 | Mlig455_022293 | Neo: - Age: - |
CASP3 | 2.65 | - | - | 0.969 | 0.924 | 0.757 | - | Mlig455_022293 {REF} {Length: 2773} {Pfam: Caspase domain [PF00656.24, score=93.1]; Ankyrin repeats (3 copies) [PF12796.9, score=77.8]; Ankyrin repeats (many copies) [PF13857.8, score=62.2]; Ankyrin repeats (many copies) [PF13637.8, score=56.0]; Ankyrin repeat [PF13606.8, score=39.1]; Ankyrin repeat [PF00023.32, score=28.2]} {Human: ENSG00000164305, CASP3, caspase 3, [Score=109, Expect=7e-26]; ENSG00000003400, CASP10, caspase 10, [Score=107, Expect=9e-24]; ENSG00000165806, CASP7, caspase 7, [Score=104, Expect=2e-23]} {Mouse: ENSMUSG00000025076, Casp7, caspase 7, [Score=106, Expect=9e-25]; ENSMUSG00000031628, Casp3, caspase 3, [Score=103, Expect=3e-24]} {Dmel: FBgn0010501, Dcp-1, Death caspase-1, [Score=96.3, Expect=3e-21]} {Celegans: WBGene00000417, ced-3, Cell death protein 3 Cell death protein 3 subunit 1 Cell death protein 3 subunit 2, [Score=81.6, Expect=9e-17]} {Smed: dd_Smed_v6_3121_1_1, dd_Smed_v6_3121_1_1, [Score=102, Expect=3e-24]} {RNA1509_54818} {RNA1310_7187, RNA1509_54818} {RNA1509_54818, RNA815_8712} |
12. | MligTC455_23150 | 3195 | 66.56 | Mlig455_009524, Mlig455_009530 | Neo: - Age: - Region-enriched R2: 3.504/0.00000 |
CDK16 | 2.64 | - | - | 0.944 | 0.724 | 0.972 | - | Mlig455_009524 {REF} {Length: 3287} {Pfam: Protein kinase domain [PF00069.27, score=218.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.2]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [RH, Score=463, Expect=7e-159]; ENSG00000059758, CDK17, cyclin dependent kinase 17, [RH, Score=447, Expect=2e-151]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [RH, Score=464, Expect=2e-158]; ENSMUSG00000020015, Cdk17, cyclin-dependent kinase 17, [RH, Score=449, Expect=2e-152]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=362, Expect=2e-118]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [RH, Score=417, Expect=3e-138]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [RH, Score=449, Expect=6e-151]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} Mlig455_009530 {REF} {Length: 3384} {Pfam: Protein kinase domain [PF00069.27, score=208.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=114.4]; Haspin like kinase domain [PF12330.10, score=17.8]} {Human: ENSG00000102225, CDK16, cyclin dependent kinase 16, [Score=432, Expect=5e-147]} {Mouse: ENSMUSG00000031065, Cdk16, cyclin-dependent kinase 16, [Score=431, Expect=4e-146]} {Dmel: FBgn0005640, Eip63E, Ecdysone-induced protein 63E, [Score=329, Expect=9e-107]} {Celegans: WBGene00003961, pct-1, Cyclin-dependent kinase 17, [Score=392, Expect=2e-130]} {Smed: dd_Smed_v6_4172_0_4, dd_Smed_v6_4172_0_4, [Score=411, Expect=6e-137]} {RNA1509_23462} {RNA1310_21506} {RNA815_9702} |
13. | MligTC455_49296 | 69 | 1.44 | Mlig455_034352, Mlig455_034414 | Neo: - Age: - |
2.617 | - | - | 0.897 | 0.767 | 0.953 | - | Mlig455_034352 {REF} {Length: 912} {TRANSSPLICED} Mlig455_034414 {REF} {Length: 919} {TRANSSPLICED} |
|
14. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
2.607 | - | - | 0.939 | 0.706 | 0.962 | - | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
15. | MligTC455_09313 | 673 | 14.01 | Mlig455_021865, Mlig455_021943 | Neo: - Age: Up-Down-Down Region-enriched R2: 2.967/0.00176 |
2.607 | - | - | 0.816 | 0.835 | 0.956 | - | Mlig455_021865 {REF} {Length: 5096} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [Score=79.3, Expect=1e-14]} {RNA1509_22941} {RNA1310_4839.1} {RNA815_8984} Mlig455_021943 {REF} {Length: 5863} {Smed: dd_Smed_v6_13587_0_1, dd_Smed_v6_13587_0_1, [RH, Score=83.6, Expect=7e-16]} {RNA1509_22941} {RNA1310_4839.1, RNA1509_22941} {RNA1509_22941, RNA815_15728} |
|
16. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
2.595 | - | - | 0.788 | 0.977 | 0.830 | - | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
17. | MligTC455_47780 | 214 | 4.46 | Mlig455_018842, Mlig455_018853 | Neo: - Age: - |
2.594 | - | - | 0.980 | 0.747 | 0.867 | - | Mlig455_018842 {REF} {Length: 500} {RNA1509_48336} {RNA1310_73351} {RNA815_41082} Mlig455_018853 {REF} {Length: 593} {RNA1509_48336} {RNA1310_73351, RNA1509_48336} {RNA1509_48336, RNA815_41082} |
|
18. | MligTC455_44713 | 661 | 13.77 | Mlig455_048154 | Neo: - Age: logFC(26M/2M)=0.569 Region-specific R2: 3.883 Region-enriched R2: 3.422/0.00000 |
2.586 | - | - | 0.734 | 0.896 | 0.956 | - | Mlig455_048154 {REF} {Length: 1173} {RNA1509_34252} {RNA1310_54269.1} {RNA815_55074} | |
19. | MligTC455_29100 | 53 | 1.11 | Mlig455_022386, Mlig455_022475 | Neo: - Age: - Region-enriched R2: 7.567/0.00114 |
KREMEN2 | 2.583 | - | - | 0.984 | 0.853 | 0.746 | - | Mlig455_022386 {REF} {Length: 4145} {tRNA: Val(CAC),pseudo, score=29.3} {Pfam: WSC domain [PF01822.21, score=45.2]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=48.5, Expect=3e-06]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=47.0, Expect=7e-06]} {RNA1509_55375} {RNA1310_18706} {RNA815_23500} Mlig455_022475 {REF} {Length: 3047} {Pfam: WSC domain [PF01822.21, score=46.0]; PAN domain [PF00024.28, score=23.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=51.2, Expect=4e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=53.5, Expect=5e-08]} {RNA1509_47157} {RNA1310_35396.1} {RNA815_23500} |
20. | MligTC455_43389 | 18 | 0.38 | Mlig455_019091 | Neo: - Age: - |
PRKAR2A | 2.58 | - | - | 0.771 | 0.968 | 0.841 | - | Mlig455_019091 {REF} {Length: 2410} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=122.4]; Regulatory subunit of type II PKA R-subunit [PF02197.19, score=40.5]} {Human: ENSG00000114302, PRKAR2A, protein kinase cAMP-dependent type II regulatory subunit alpha, [Score=305, Expect=2e-100]; ENSG00000005249, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]; ENSG00000284096, PRKAR2B, protein kinase cAMP-dependent type II regulatory subunit beta, [Score=297, Expect=5e-97]} {Mouse: ENSMUSG00000032601, Prkar2a, protein kinase, cAMP dependent regulatory, type II alpha, [Score=313, Expect=9e-104]} {Dmel: FBgn0022382, Pka-R2, Protein kinase, cAMP-dependent, regulatory subunit type 2, [Score=335, Expect=1e-112]} {Celegans: WBGene00002190, kin-2, cAMP-dependent protein kinase regulatory subunit, [Score=219, Expect=2e-68]} {Smed: dd_Smed_v6_4188_0_1, dd_Smed_v6_4188_0_1, [Score=335, Expect=6e-113]} {RNA1509_34470} {RNA1310_27777} {RNA815_5628} |
21. | MligTC455_38227 | 131 | 2.73 | Mlig455_049364 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.468/0.02435 |
2.565 | - | - | 0.793 | 0.963 | 0.809 | - | Mlig455_049364 {REF} {Length: 726} {RNA1509_22173} {RNA1310_65747} {RNA815_15489} | |
22. | MligTC455_41823 | 300 | 6.25 | Mlig455_022277 | Neo: - Age: - Region-enriched R2: 3.150/0.00185 |
2.561 | - | - | 0.718 | 0.887 | 0.956 | - | Mlig455_022277 {REF} {Length: 753} {RNA1509_49797} {RNA1310_60350} {RNA815_30999} | |
23. | MligTC455_04855 | 16 | 0.34 | Mlig455_005010, Mlig455_005053, Mlig455_005260 | Neo: - Age: logFC(26M/2M)=0.904 |
HCRTR2 | 2.555 | - | - | 0.976 | 0.800 | 0.779 | - | Mlig455_005010 {REF} {Length: 1532} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=207, Expect=5e-61]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=209, Expect=7e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=8e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=4e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=7e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005053 {REF} {Length: 3639} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} Mlig455_005260 {REF} {Length: 1614} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=156.6]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=29.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=23.9]} {Human: ENSG00000137252, HCRTR2, hypocretin receptor 2, [RH, Score=210, Expect=6e-62]} {Mouse: ENSMUSG00000032360, Hcrtr2, hypocretin (orexin) receptor 2, [Score=211, Expect=1e-62]} {Dmel: FBgn0038880, SIFaR, SIFamide receptor, [Score=150, Expect=7e-39]} {Celegans: WBGene00022004, npr-22, NeuroPeptide Receptor family, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_22624_0_1, dd_Smed_v6_22624_0_1, [RH, Score=215, Expect=6e-65]} {RNA1310_58724} {RNA815_36016} |
24. | MligTC455_11109 | 30 | 0.62 | Mlig455_043718, Mlig455_043804 | Neo: - Age: Up-Down-Down |
2.55 | - | - | 0.954 | 0.736 | 0.860 | - | Mlig455_043718 {REF} {Length: 1591} {RNA1310_49834.1} {RNA815_39415} Mlig455_043804 {REF} {Length: 1594} {RNA1310_49834.2} {RNA815_39415} |
|
25. | MligTC455_14856 | 14 | 0.29 | Mlig455_023184 | Neo: - Age: - |
ANGPTL7 | 2.547 | - | - | 0.724 | 0.978 | 0.845 | - | Mlig455_023184 {REF} {Length: 1290} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]; PAN domain [PF00024.28, score=23.8]} {Human: ENSG00000171819, ANGPTL7, angiopoietin like 7, [Score=105, Expect=1e-25]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=103, Expect=3e-24]} {Mouse: ENSMUSG00000028989, Angptl7, angiopoietin-like 7, [Score=104, Expect=1e-25]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=102, Expect=4e-24]} {Dmel: FBgn0033312, CG8642, [Score=96.7, Expect=2e-22]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=98.6, Expect=5e-23]} {RNA1509_58115} {RNA1310_36699.1} {RNA815_17918.1} |
26. | MligTC455_24064 | 359 | 7.48 | Mlig455_048183 | Neo: - Age: - |
SNAP25 | 2.542 | - | - | 0.846 | 0.724 | 0.972 | - | Mlig455_048183 {REF} {Length: 1315} {Pfam: SNAP-25 family [PF00835.21, score=41.5]} {Human: ENSG00000132639, SNAP25, synaptosome associated protein 25, [Score=219, Expect=7e-72]} {Mouse: ENSMUSG00000027273, Snap25, synaptosomal-associated protein 25, [Score=219, Expect=5e-72]} {Dmel: FBgn0266720, Snap24, Synaptosomal-associated protein 24kDa, [RH, Score=228, Expect=1e-75]} {Celegans: WBGene00004364, ric-4, Synaptosomal-associated protein, [RH, Score=257, Expect=2e-87]} {Smed: dd_Smed_v6_3977_0_1, dd_Smed_v6_3977_0_1, [RH, Score=282, Expect=2e-97]} {RNA1509_8624} {RNA1310_24253} {RNA815_10439} |
27. | MligTC455_40290 | 58 | 1.21 | Mlig455_058728 | Neo: - Age: - Region-enriched R2: 4.464/0.00807 |
2.532 | - | - | 0.962 | 0.771 | 0.799 | - | Mlig455_058728 {REF} {Length: 1351} {Pfam: CUB domain [PF00431.22, score=48.4]} {RNA1310_48745} {RNA815_23305} | |
28. | MligTC455_51764 | 938 | 19.55 | Mlig455_016061 | Neo: - Age: - Region-specific R2: 2.881 Region-enriched R2: 1.672/0.00180 |
2.524 | - | - | 0.772 | 0.952 | 0.800 | - | Mlig455_016061 {REF} {Length: 649} {RNA1509_58232} {RNA1310_60107.1, RNA1509_58232} {RNA1509_58232, RNA815_31573} | |
29. | MligTC455_19040 | 49 | 1.03 | Mlig455_003437 | Neo: - Age: - Region-enriched R2: 6.133/0.00615 |
CAV1 | 2.514 | - | - | 0.775 | 0.757 | 0.982 | - | Mlig455_003437 {REF} {Length: 808} {Pfam: Caveolin [PF01146.19, score=118.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=101, Expect=7e-28]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=102, Expect=2e-28]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=73.6, Expect=9e-17]} {Smed: dd_Smed_v6_13481_0_1, dd_Smed_v6_13481_0_1, [RH, Score=142, Expect=8e-45]} {RNA1509_53381} {RNA1310_97043} {RNA815_32565} |
30. | MligTC455_31031 | 361 | 7.53 | Mlig455_009779 | Neo: - Age: - Region-enriched R2: 2.821/0.00350 |
LRRN3 | 2.51 | - | - | 0.702 | 0.854 | 0.954 | - | Mlig455_009779 {REF} {Length: 3647} {Pfam: Immunoglobulin domain [PF13927.8, score=35.5]; Immunoglobulin I-set domain [PF07679.18, score=34.5]; Immunoglobulin domain [PF00047.27, score=29.1]; Apolipoprotein A1/A4/E domain [PF01442.20, score=19.2]} {Human: ENSG00000173114, LRRN3, leucine rich repeat neuronal 3, [Score=56.2, Expect=2e-07]} {Dmel: FBgn0032479, CG16974, [RH, Score=116, Expect=3e-26]} {RNA1509_10344} {RNA1310_3046.1} {RNA815_12103} |
31. | MligTC455_34987 | 27 | 0.56 | Mlig455_031823, Mlig455_047624, Mlig455_047675 | Neo: - Age: - |
KREMEN2 | 2.508 | - | - | 0.720 | 0.988 | 0.800 | - | Mlig455_031823 {REF} {Length: 873} {Pfam: WSC domain [PF01822.21, score=52.7]; PAN domain [PF00024.28, score=21.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=50.4, Expect=4e-07]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=60.1, Expect=2e-10]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=47.8, Expect=2e-06]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047624 {REF} {Length: 824} {Pfam: WSC domain [PF01822.21, score=55.0]; PAN domain [PF00024.28, score=22.2]; PAN domain [PF14295.8, score=19.1]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=5e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.5, Expect=1e-11]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=4e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} Mlig455_047675 {REF} {Length: 2718} {Pfam: WSC domain [PF01822.21, score=53.8]; PAN domain [PF00024.28, score=21.8]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.2, Expect=6e-09]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=65.5, Expect=4e-12]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=49.7, Expect=6e-07]} {RNA1509_53783} {RNA1310_52135.1} {RNA815_24434} |
32. | MligTC455_12992 | 102 | 2.12 | Mlig455_034920 | Neo: - Age: - Region-enriched R2: 3.155/0.02568 |
RAC2 | 2.492 | - | - | 0.799 | 0.737 | 0.956 | - | Mlig455_034920 {REF} {Length: 3245} {Pfam: Ras family [PF00071.24, score=175.5]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=80.0]; ADP-ribosylation factor family [PF00025.23, score=32.7]} {Human: ENSG00000128340, RAC2, Rac family small GTPase 2, [Score=277, Expect=1e-95]; ENSG00000136238, RAC1, Rac family small GTPase 1, [Score=273, Expect=6e-94]} {Mouse: ENSMUSG00000033220, Rac2, Rac family small GTPase 2, [Score=275, Expect=3e-95]; ENSMUSG00000001847, Rac1, Rac family small GTPase 1, [Score=273, Expect=4e-94]; ENSMUSG00000018012, Rac3, Rac family small GTPase 3, [Score=263, Expect=3e-90]} {Dmel: FBgn0010333, Rac1, [Score=270, Expect=2e-93]} {Celegans: WBGene00000424, ced-10, Ras-related protein ced-10, [Score=268, Expect=2e-92]} {Smed: dd_Smed_v6_610_0_1, dd_Smed_v6_610_0_1, [Score=251, Expect=4e-86]} {RNA1509_26483} {RNA1310_31644} {RNA815_16762} |
33. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 2.488 | - | - | 0.953 | 0.705 | 0.830 | - | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
34. | MligTC455_33440 | 62 | 1.29 | Mlig455_053806, Mlig455_053807 | Neo: - Age: Up-Down-Down Region-enriched R2: 5.142/0.02950 |
GRID1 | 2.487 | - | - | 0.993 | 0.701 | 0.793 | - | Mlig455_053806 {REF} {Length: 3070} {Pfam: Ligand-gated ion channel [PF00060.28, score=72.9]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.7]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=39.8]; Receptor family ligand binding region [PF01094.30, score=28.6]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=145, Expect=2e-35]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=143, Expect=2e-34]} {Dmel: FBgn0038837, CG3822, [Score=126, Expect=2e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=112, Expect=3e-25]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=257, Expect=1e-77]} {RNA1310_13880.2} {RNA815_12458} Mlig455_053807 {REF} {Length: 3142} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.5]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=46.3]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=38.3]; Receptor family ligand binding region [PF01094.30, score=36.5]} {Human: ENSG00000182771, GRID1, glutamate ionotropic receptor delta type subunit 1, [Score=139, Expect=2e-33]} {Mouse: ENSMUSG00000041078, Grid1, glutamate receptor, ionotropic, delta 1, [Score=137, Expect=1e-32]} {Dmel: FBgn0038837, CG3822, [Score=125, Expect=5e-29]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=117, Expect=1e-26]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=259, Expect=2e-78]} {RNA1310_13880.2} {RNA815_12458} |
35. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.437 | - | - | 0.965 | 0.730 | 0.742 | - | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
36. | MligTC455_17579 | 76 | 1.58 | Mlig455_042836, Mlig455_045854, Mlig455_045870 | Neo: - Age: - |
RNF217 | 2.395 | - | - | 0.979 | 0.707 | 0.709 | - | Mlig455_042836 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=75.3]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.6, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.0, Expect=4e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045854 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.7]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.8, Expect=2e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} Mlig455_045870 {REF} {Length: 3004} {Pfam: IBR domain, a half RING-finger domain [PF01485.23, score=74.9]} {Human: ENSG00000146373, RNF217, ring finger protein 217, [Score=83.2, Expect=5e-16]} {Mouse: ENSMUSG00000063760, Rnf217, ring finger protein 217, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0036082, CG12362, [Score=57.4, Expect=3e-08]} {Celegans: WBGene00020462, T12E12.1, Potential E3 ubiquitin-protein ligase ariadne-2, [Score=57.0, Expect=4e-08]} {Smed: dd_Smed_v6_7986_0_1, dd_Smed_v6_7986_0_1, [Score=61.2, Expect=1e-09]} {RNA1310_42946} {RNA815_24345} |
37. | MligTC455_44094 | 90 | 1.88 | Mlig455_018759 | Neo: - Age: - |
PCDH17 | 2.382 | - | - | 0.715 | 0.708 | 0.959 | - | Mlig455_018759 {REF} {Length: 3612} {Pfam: Cadherin domain [PF00028.19, score=240.7]; Cadherin-like [PF16184.7, score=28.6]; Cadherin-like [PF08266.14, score=27.8]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=263, Expect=1e-73]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=264, Expect=7e-73]; ENSMUSG00000051323, Pcdh19, protocadherin 19, [RH, Score=261, Expect=6e-72]; ENSMUSG00000104063, Pcdhgb7, protocadherin gamma subfamily B, 7, [RH, Score=260, Expect=2e-72]} {Dmel: FBgn0024836, stan, starry night, [Score=215, Expect=1e-56]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=176, Expect=2e-44]} {Smed: dd_Smed_v6_21489_0_1, dd_Smed_v6_21489_0_1, [Score=283, Expect=5e-81]} {RNA1509_38737} {RNA1310_26793, RNA1509_38737} {RNA1509_38737, RNA815_46826} |
38. | MligTC455_47704 | 106 | 2.21 | Mlig455_032247 | Neo: - |
WSCD2 | 1.968 | - | - | - | 0.995 | 0.973 | - | Mlig455_032247 {REF} {Length: 2305} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=54.7, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=56.6, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=63.9, Expect=1e-10]} {RNA1509_59284} {RNA1310_13567} {RNA815_27780} |
39. | MligTC455_16866 | 18 | 0.37 | Mlig455_065296 | Neo: - Age: - |
1.966 | - | - | - | 0.983 | 0.983 | - | Mlig455_065296 {REF} {Length: 1827} {RNA1310_92472} | |
40. | MligTC455_16867 | 18 | 0.37 | Mlig455_065319 | Neo: - Age: - |
1.966 | - | - | - | 0.983 | 0.983 | - | Mlig455_065319 {REF} {Length: 1743} {RNA1310_92472} | |
41. | MligTC455_25382 | 4668 | 97.26 | Mlig455_000103, Mlig455_063773 | Neo: - Age: - Region-specific R2: 3.508 Region-enriched R2: 3.123/0.00000 |
1.949 | - | - | - | 0.978 | 0.971 | - | Mlig455_000103 {REF} {Length: 990} {RNA1509_36813} {RNA1310_39295, RNA1509_36813} {RNA1509_36813, RNA815_13177} Mlig455_063773 {REF} {Length: 890} {RNA1509_6028} {RNA1310_39295} {RNA815_13177} |
|
42. | MligTC455_13074 | 12 | 0.24 | Mlig455_061874 | Neo: - Age: - |
STOM | 1.947 | - | - | 0.995 | - | 0.952 | - | Mlig455_061874 {REF} {Length: 1208} {Pfam: SPFH domain / Band 7 family [PF01145.27, score=99.9]} {Human: ENSG00000148175, STOM, stomatin, [Score=261, Expect=9e-86]; ENSG00000133115, STOML3, stomatin like 3, [Score=251, Expect=5e-82]} {Mouse: ENSMUSG00000026880, Stom, stomatin, [Score=256, Expect=4e-84]; ENSMUSG00000027744, Stoml3, stomatin (Epb7.2)-like 3, [Score=244, Expect=3e-79]} {Dmel: FBgn0260657, CG42540, [Score=261, Expect=7e-85]} {Celegans: WBGene00006063, sto-1, Stomatin-1, [Score=261, Expect=9e-86]} {Smed: dd_Smed_v6_6396_0_1, dd_Smed_v6_6396_0_1, [Score=292, Expect=2e-98]} {RNA1310_123385} |
43. | MligTC455_51780 | 138 | 2.88 | Mlig455_046894 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.174/0.00338 |
PNPO | 1.943 | - | - | - | 0.981 | 0.962 | - | Mlig455_046894 {REF} {Length: 2339} {Pfam: Pyridoxamine 5'-phosphate oxidase [PF01243.22, score=78.4]; Pyridoxine 5'-phosphate oxidase C-terminal dimerisation region [PF10590.11, score=69.2]; Pyridoxamine 5'-phosphate oxidase [PF12766.9, score=22.3]} {Human: ENSG00000108439, PNPO, pyridoxamine 5'-phosphate oxidase, [Score=182, Expect=7e-57]} {Mouse: ENSMUSG00000018659, Pnpo, pyridoxine 5'-phosphate oxidase, [RH, Score=184, Expect=1e-57]} {Dmel: FBgn0051472, sgll, sugarlethal, [Score=168, Expect=6e-52]} {Celegans: WBGene00018996, F57B9.1, Putative pyridoxamine 5'-phosphate oxidase, [RH, Score=200, Expect=1e-64]} {Smed: dd_Smed_v6_5086_0_1, dd_Smed_v6_5086_0_1, [RH, Score=177, Expect=2e-55]} {RNA1509_54079} {RNA1310_31564.1, RNA1509_54079} {RNA1509_54079, RNA815_34098} |
44. | MligTC455_12105 | 21 | 0.43 | Mlig455_015631 | Neo: - Age: - |
1.941 | - | - | - | 0.984 | 0.957 | - | Mlig455_015631 {REF} {Length: 1685} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=27.3]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=22.5]} {Smed: dd_Smed_v6_13742_0_1, dd_Smed_v6_13742_0_1, [Score=82.4, Expect=2e-17]} {RNA1310_95837} | |
45. | MligTC455_09224 | 21 | 0.43 | Mlig455_038078 | Neo: - Age: - |
1.935 | - | - | 0.984 | 0.951 | - | - | Mlig455_038078 {REF} {Length: 771} {Pfam: PAN domain [PF00024.28, score=28.0]} {RNA1509_46267} {RNA1310_51656} {RNA815_32275.1} | |
46. | MligTC455_47741 | 102 | 2.13 | Mlig455_004211 | Neo: - Age: Down-Up-Up |
1.928 | - | - | - | 0.963 | 0.965 | - | Mlig455_004211 {REF} {Length: 1794} {RNA1310_23101} {RNA815_45601} | |
47. | MligTC455_49862 | 26 | 0.54 | Mlig455_019435 | Neo: - Age: - |
SHOX2 | 1.927 | - | - | - | 0.970 | 0.957 | - | Mlig455_019435 {REF} {Length: 904} {Pfam: Homeodomain [PF00046.31, score=84.8]; Homeobox KN domain [PF05920.13, score=23.6]} {Human: ENSG00000168779, SHOX2, short stature homeobox 2, [Score=89.0, Expect=4e-22]; ENSG00000185960, SHOX, short stature homeobox, [Score=87.0, Expect=5e-21]} {Mouse: ENSMUSG00000027833, Shox2, short stature homeobox 2, [Score=89.0, Expect=3e-22]} {Dmel: FBgn0085396, CG34367, [Score=89.7, Expect=9e-22]} {Celegans: WBGene00006744, unc-4, Homeobox protein unc-4, [Score=83.6, Expect=5e-20]} {Smed: dd_Smed_v6_22163_0_1, dd_Smed_v6_22163_0_1, [Score=86.3, Expect=2e-20]} {RNA1310_51707} {RNA815_41055} |
48. | MligTC455_38775 | 266 | 5.54 | Mlig455_066758, Mlig455_069705 | Neo: - Age: - Region-specific R2: 6.147 Region-enriched R2: 5.505/0.02411 |
WNT6 | 1.926 | - | - | - | 0.983 | 0.943 | - | Mlig455_066758 {REF} {Length: 2739} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=9e-15]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=6e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=74.3, Expect=9e-14]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.9, Expect=4e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=71.2, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.2} {RNA815_8552} Mlig455_069705 {REF} {Length: 2713} {Pfam: wnt family [PF00110.21, score=158.2]} {Human: ENSG00000115596, WNT6, Wnt family member 6, [Score=77.4, Expect=1e-14]; ENSG00000134245, WNT2B, Wnt family member 2B, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000033227, Wnt6, wingless-type MMTV integration site family, member 6, [Score=74.3, Expect=7e-14]; ENSMUSG00000027840, Wnt2b, wingless-type MMTV integration site family, member 2B, [Score=73.9, Expect=1e-13]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=70.9, Expect=9e-13]} {Celegans: WBGene00000857, cwn-1, [Score=73.6, Expect=6e-14]} {Smed: dd_Smed_v6_13487_0_1, dd_Smed_v6_13487_0_1, [Score=70.9, Expect=3e-13]} {RNA1509_23528} {RNA1310_12823.1, RNA1509_23528} {RNA1509_23528, RNA815_8552} |
49. | MligTC455_52727 | 82 | 1.72 | Mlig455_043336 | Neo: - Age: Down-Up-Down |
1.925 | - | - | - | 0.961 | 0.964 | - | Mlig455_043336 {REF} {Length: 1410} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=60.5]; Capsular polysaccharide synthesis protein [PF05704.14, score=20.9]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=131, Expect=4e-35]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
50. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
1.923 | - | - | 0.981 | - | 0.942 | - | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
51. | MligTC455_46581 | 31 | 0.64 | Mlig455_042524 | Neo: - Age: - |
1.922 | - | - | - | 0.999 | 0.923 | - | Mlig455_042524 {REF} {Length: 975} {RNA1509_46101} {RNA1310_32444} {RNA815_42659} | |
52. | MligTC455_45080 | 3677 | 76.61 | Mlig455_021478, Mlig455_062024, Mlig455_063226, Mlig455_067363 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.291 Region-enriched R8: 1.930/0.00003 |
1.918 | - | - | - | 0.964 | 0.954 | - | Mlig455_021478 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_062024 {REF} {Length: 752} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_063226 {REF} {Length: 753} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} Mlig455_067363 {REF} {Length: 767} {RNA1509_11225} {RNA1310_43601} {RNA815_21702} |
|
53. | MligTC455_10754 | 10 | 0.2 | Mlig455_035686 | Neo: - Age: - |
OTX2 | 1.915 | - | - | 0.987 | - | 0.928 | - | Mlig455_035686 {REF} {Length: 2705} {Pfam: Homeodomain [PF00046.31, score=73.1]} {Human: ENSG00000165588, OTX2, orthodenticle homeobox 2, [RH, Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000021848, Otx2, orthodenticle homeobox 2, [RH, Score=127, Expect=6e-34]} {Dmel: FBgn0004102, oc, ocelliless, [RH, Score=124, Expect=2e-30]} {Celegans: WBGene00006652, ttx-1, Homeodomain protein TTX-1, [Score=120, Expect=3e-30]} {Smed: dd_Smed_v6_14633_0_1, dd_Smed_v6_14633_0_1, [RH, Score=102, Expect=3e-23]} {RNA1509_34770} {RNA1310_31442} {RNA815_3742.2} |
54. | MligTC455_10755 | 10 | 0.2 | Mlig455_035782 | Neo: - Age: - |
OTX2 | 1.915 | - | - | 0.987 | - | 0.928 | - | Mlig455_035782 {REF} {Length: 1715} {Pfam: Homeodomain [PF00046.31, score=73.1]} {Human: ENSG00000165588, OTX2, orthodenticle homeobox 2, [RH, Score=127, Expect=5e-33]} {Mouse: ENSMUSG00000021848, Otx2, orthodenticle homeobox 2, [RH, Score=127, Expect=6e-34]} {Dmel: FBgn0004102, oc, ocelliless, [RH, Score=124, Expect=2e-30]} {Celegans: WBGene00006652, ttx-1, Homeodomain protein TTX-1, [Score=120, Expect=3e-30]} {Smed: dd_Smed_v6_14633_0_1, dd_Smed_v6_14633_0_1, [RH, Score=102, Expect=3e-23]} {RNA1509_34770} {RNA1310_31442} {RNA815_3742.2} |
55. | MligTC455_45123 | 17 | 0.35 | Mlig455_003259, Mlig455_062838 | Neo: - Age: - |
1.914 | - | - | 0.994 | - | 0.920 | - | Mlig455_003259 {REF} {Length: 988} {Pfam: WSC domain [PF01822.21, score=59.6]; PAN domain [PF00024.28, score=21.3]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=61.2, Expect=1e-10]} {RNA1509_42596} {RNA1310_44497} {RNA815_21593} Mlig455_062838 {REF} {Length: 844} {Pfam: PAN domain [PF00024.28, score=27.6]} {RNA1509_39816} {RNA1310_44497} {RNA815_21593} |
|
56. | MligTC455_46285 | 568 | 11.84 | Mlig455_063390 | Neo: - Age: logFC(26M/2M)=0.488 Region-enriched R2: 4.933/0.00026 |
1.914 | - | - | - | 0.986 | 0.928 | - | Mlig455_063390 {REF} {Length: 871} {RNA1509_48573} {RNA1310_59611, RNA1509_48573} {RNA1509_48573, RNA815_35731} | |
57. | MligTC455_53895 | 21 | 0.43 | Mlig455_053958 | Neo: - Age: - |
1.911 | - | - | 0.962 | - | 0.949 | - | Mlig455_053958 {REF} {Length: 208} {NoTransDecoderORF} {RNA1310_28234} {RNA815_49657} | |
58. | MligTC455_13563 | 29 | 0.6 | Mlig455_057359, Mlig455_059570 | Neo: - Age: - |
1.91 | - | - | 0.976 | - | 0.934 | - | Mlig455_057359 {REF} {Length: 700} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} Mlig455_059570 {REF} {Length: 395} {NoTransDecoderORF} {RNA1310_89069} {RNA815_57947} |
|
59. | MligTC455_43676 | 56 | 1.16 | Mlig455_058053, Mlig455_058096 | Neo: - Age: - |
1.909 | - | - | - | 0.990 | 0.919 | - | Mlig455_058053 {REF} {Length: 391} {NoTransDecoderORF} {RNA1509_25254} {RNA1310_102705} {RNA815_52459} Mlig455_058096 {REF} {Length: 1983} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=51.3]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=90.1, Expect=1e-19]} {RNA1509_1472} {RNA1310_25467} {RNA815_39314} |
|
60. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 1.909 | - | - | - | 0.952 | 0.957 | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
61. | MligTC455_35773 | 89 | 1.86 | Mlig455_064449, Mlig455_064456 | Neo: - Age: - Region-enriched R2: 5.198/0.00725 |
NANP | 1.907 | - | - | 0.958 | - | 0.949 | - | Mlig455_064449 {REF} {Length: 503} {NoTransDecoderORF} {RNA1310_53432.2} Mlig455_064456 {REF} {Length: 3122} {Pfam: Haloacid dehalogenase-like hydrolase [PF13419.8, score=56.3]; haloacid dehalogenase-like hydrolase [PF00702.28, score=55.3]; HAD-hyrolase-like [PF13242.8, score=44.6]} {Human: ENSG00000170191, NANP, N-acetylneuraminic acid phosphatase, [RH, Score=47.4, Expect=8e-06]} {Mouse: ENSMUSG00000053916, Nanp, N-acetylneuraminic acid phosphatase, [RH, Score=48.5, Expect=2e-06]} {Celegans: WBGene00018465, F45E1.4, [RH, Score=147, Expect=4e-43]} {Smed: dd_Smed_v6_2813_0_3, dd_Smed_v6_2813_0_3, [Score=174, Expect=2e-50]} {RNA1310_59243} {RNA815_62364} |
62. | MligTC455_12847 | 25 | 0.51 | Mlig455_049599 | Neo: - Age: - |
1.906 | - | - | 0.969 | - | 0.937 | - | Mlig455_049599 {REF} {Length: 1963} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.4]; Olfactory receptor [PF13853.8, score=24.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.1]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [RH, Score=91.7, Expect=1e-19]} {Smed: dd_Smed_v6_35525_0_1, dd_Smed_v6_35525_0_1, [Score=144, Expect=1e-38]} {RNA1310_85894} {RNA815_45174} | |
63. | MligTC455_40648 | 60 | 1.24 | Mlig455_034479 | Neo: - Age: Down-Up-Up |
1.903 | - | - | - | 0.987 | 0.916 | - | Mlig455_034479 {REF} {Length: 2499} {RNA1310_42980.1} {RNA815_47590} | |
64. | MligTC455_41226 | 44 | 0.92 | Mlig455_019357, Mlig455_059122 | Neo: - Age: - |
GALNT1 | 1.903 | - | - | 0.959 | - | 0.944 | - | Mlig455_019357 {REF} {Length: 1606} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=97.5]; Glycosyltransferase like family 2 [PF13641.8, score=38.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.1]; Glycosyltransferase like family 2 [PF10111.11, score=18.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=318, Expect=2e-103]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=311, Expect=4e-100]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=305, Expect=3e-98]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=305, Expect=3e-98]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=316, Expect=1e-102]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=308, Expect=9e-99]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=302, Expect=3e-97]} {Dmel: FBgn0050463, CG30463, [Score=345, Expect=5e-113]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=350, Expect=3e-115]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=353, Expect=1e-117]} {RNA1310_25598} {RNA815_36943} Mlig455_059122 {REF} {Length: 2150} {Pfam: Glycosyl transferase family 2 [PF00535.28, score=96.4]; Glycosyltransferase like family 2 [PF13641.8, score=35.9]; N-terminal domain of galactosyltransferase [PF02709.16, score=29.5]} {Human: ENSG00000141429, GALNT1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=313, Expect=2e-101]; ENSG00000139629, GALNT6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=307, Expect=2e-98]; ENSG00000257594, GALNT4, polypeptide N-acetylgalactosaminyltransferase 4, [Score=300, Expect=6e-96]; ENSG00000259075, POC1B-GALNT4, POC1B-GALNT4 readthrough, [Score=299, Expect=7e-96]; ENSG00000144278, GALNT13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=1e-95]} {Mouse: ENSMUSG00000000420, Galnt1, polypeptide N-acetylgalactosaminyltransferase 1, [Score=311, Expect=1e-100]; ENSMUSG00000037280, Galnt6, polypeptide N-acetylgalactosaminyltransferase 6, [Score=305, Expect=1e-97]; ENSMUSG00000060988, Galnt13, polypeptide N-acetylgalactosaminyltransferase 13, [Score=298, Expect=8e-96]; ENSMUSG00000026994, Galnt3, polypeptide N-acetylgalactosaminyltransferase 3, [Score=296, Expect=5e-94]; ENSMUSG00000026828, Galnt5, polypeptide N-acetylgalactosaminyltransferase 5, [Score=296, Expect=2e-91]} {Dmel: FBgn0050463, CG30463, [Score=340, Expect=3e-111]} {Celegans: WBGene00001630, gly-5, Polypeptide N-acetylgalactosaminyltransferase 5, [Score=344, Expect=3e-113]} {Smed: dd_Smed_v6_8580_0_1, dd_Smed_v6_8580_0_1, [Score=350, Expect=3e-116]} {RNA1310_25598} {RNA815_36943} |
65. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 1.903 | - | - | 0.952 | - | 0.951 | - | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
66. | MligTC455_45063 | 105 | 2.19 | Mlig455_045829, Mlig455_045845, Mlig455_045862 | Neo: - Age: - |
1.902 | - | - | 0.976 | - | 0.926 | - | Mlig455_045829 {REF} {Length: 4186} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045845 {REF} {Length: 3433} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=149.9]} {Celegans: WBGene00003174, mec-10, Degenerin mec-10, [Score=61.2, Expect=1e-09]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=101, Expect=1e-22]} {RNA1509_43949} {RNA1310_15301.1} {RNA815_26865} Mlig455_045862 {REF} {Length: 3524} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=185.3]} {Celegans: WBGene00016064, acd-1, [Score=70.9, Expect=1e-12]} {Smed: dd_Smed_v6_19599_0_1, dd_Smed_v6_19599_0_1, [Score=120, Expect=1e-28]} {RNA1509_43949} {RNA1310_15301.1, RNA1509_43949} {RNA1509_43949, RNA815_26865} |
|
67. | MligTC455_45134 | 9943 | 207.14 | Mlig455_022505 | Neo: - Age: - Region-enriched R2: 1.329/0.00560 Regeneration-downregulated BL: -1.932 Regeneration-depleted BL: -1.932 |
PAM | 1.9 | - | - | - | 0.928 | 0.972 | - | Mlig455_022505 {REF} {Length: 1757} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=107.0]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=69.2]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=190, Expect=4e-54]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=186, Expect=7e-53]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [Score=219, Expect=5e-69]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [Score=224, Expect=8e-72]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [Score=255, Expect=4e-83]} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1310_15063.1, RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118} {RNA1509_2507, RNA1509_35755, RNA1509_43492, RNA1509_7118, RNA815_4981} |
68. | MligTC455_45135 | 20518 | 427.46 | Mlig455_055032, Mlig455_055049 | Neo: - Age: - Region-enriched R2: 1.186/0.02756 Regeneration-downregulated BL: -2.004 Regeneration-depleted BL: -2.004 |
PAM | 1.9 | - | - | - | 0.923 | 0.977 | - | Mlig455_055032 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.5]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.9]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [RH, Score=205, Expect=4e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=4e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=232, Expect=1e-72]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_979} {RNA1310_15063.1} {RNA815_4981} Mlig455_055049 {REF} {Length: 1756} {TRANSSPLICED} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=129.4]; Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=67.8]} {Human: ENSG00000145730, PAM, peptidylglycine alpha-amidating monooxygenase, [Score=205, Expect=3e-58]} {Mouse: ENSMUSG00000026335, Pam, peptidylglycine alpha-amidating monooxygenase, [Score=201, Expect=5e-57]} {Dmel: FBgn0283509, Phm, Peptidylglycine-alpha-hydroxylating monooxygenase, [RH, Score=233, Expect=5e-73]} {Celegans: WBGene00022144, pghm-1, Probable peptidylglycine alpha-hydroxylating monooxygenase 1, [RH, Score=239, Expect=4e-76]} {Smed: dd_Smed_v6_2646_0_1, dd_Smed_v6_2646_0_1, [RH, Score=293, Expect=1e-96]} {RNA1509_32895, RNA1509_979} {RNA1310_15063.1, RNA1509_32895, RNA1509_979} {RNA1509_32895, RNA1509_979, RNA815_4981} |
69. | MligTC455_37989 | 83 | 1.72 | Mlig455_018192 | Neo: - Age: - |
1.899 | - | - | - | 0.948 | 0.951 | - | Mlig455_018192 {REF} {Length: 1275} {Pfam: EF-hand domain pair [PF13499.8, score=36.8]; EF-hand domain [PF13405.8, score=31.2]; EF hand [PF00036.34, score=29.3]; EF-hand domain pair [PF13833.8, score=20.5]; EF hand [PF13202.8, score=19.4]} {Smed: dd_Smed_v6_1010_0_1, dd_Smed_v6_1010_0_1, [Score=105, Expect=6e-27]} {RNA1310_31713.1} {RNA815_36423} | |
70. | MligTC455_48757 | 61 | 1.28 | Mlig455_008828, Mlig455_008932 | Neo: - Age: Up-Down-Up |
DDC | 1.897 | - | - | - | 0.957 | 0.940 | - | Mlig455_008828 {REF} {Length: 2057} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=471.9]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=572, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=558, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=553, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=563, Expect=0.0]} {RNA1310_37174} {RNA815_42090} Mlig455_008932 {REF} {Length: 2145} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=470.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [RH, Score=574, Expect=0.0]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [RH, Score=559, Expect=0.0]} {Dmel: FBgn0000422, Ddc, Dopa decarboxylase, [RH, Score=554, Expect=0.0]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [RH, Score=545, Expect=0.0]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [RH, Score=564, Expect=0.0]} {RNA1310_37174} {RNA815_42090} |
71. | MligTC455_24992 | 222 | 4.62 | Mlig455_040423 | Neo: - Age: Up-Down-Down |
PTPRD | 1.896 | - | - | - | 0.934 | 0.962 | - | Mlig455_040423 {REF} {Length: 5511} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=536.0]; Fibronectin type III domain [PF00041.23, score=69.6]; Tyrosine phosphatase family [PF13350.8, score=37.9]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=33.7]; Inositol hexakisphosphate [PF14566.8, score=24.3]} {Human: ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [RH, Score=1019, Expect=0.0]; ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [RH, Score=1010, Expect=0.0]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [RH, Score=1009, Expect=0.0]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [RH, Score=1023, Expect=0.0]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [RH, Score=1011, Expect=0.0]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [RH, Score=1004, Expect=0.0]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [RH, Score=928, Expect=0.0]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [RH, Score=723, Expect=0.0]} {Smed: dd_Smed_v6_10176_0_2, dd_Smed_v6_10176_0_2, [RH, Score=962, Expect=0.0]} {RNA1509_45823, RNA1509_59220} {RNA1310_2694.1, RNA1509_45823, RNA1509_59220} {RNA1509_45823, RNA1509_59220, RNA815_2245.1} |
72. | MligTC455_24993 | 233 | 4.86 | Mlig455_050468 | Neo: - Age: Up-Down-Down |
PTPRS | 1.896 | - | - | - | 0.938 | 0.958 | - | Mlig455_050468 {REF} {Length: 2099} {Pfam: Protein-tyrosine phosphatase [PF00102.29, score=259.3]; Tyrosine phosphatase family [PF13350.8, score=26.7]; Dual specificity phosphatase, catalytic domain [PF00782.22, score=20.1]} {Human: ENSG00000105426, PTPRS, protein tyrosine phosphatase, receptor type S, [Score=499, Expect=3e-164]; ENSG00000153707, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000282932, PTPRD, protein tyrosine phosphatase, receptor type D, [Score=497, Expect=2e-163]; ENSG00000142949, PTPRF, protein tyrosine phosphatase, receptor type F, [Score=494, Expect=1e-163]} {Mouse: ENSMUSG00000028399, Ptprd, protein tyrosine phosphatase, receptor type, D, [Score=500, Expect=7e-167]; ENSMUSG00000013236, Ptprs, protein tyrosine phosphatase, receptor type, S, [Score=493, Expect=2e-162]; ENSMUSG00000033295, Ptprf, protein tyrosine phosphatase, receptor type, F, [Score=491, Expect=9e-163]} {Dmel: FBgn0000464, Lar, Leukocyte-antigen-related-like, [Score=454, Expect=7e-146]} {Celegans: WBGene00004215, ptp-3, Tyrosine-protein phosphatase Lar-like, [Score=318, Expect=9e-100]} {Smed: dd_Smed_v6_9734_0_1, dd_Smed_v6_9734_0_1, [Score=439, Expect=8e-146]} {RNA1509_59220} {RNA1310_403.1} {RNA815_2245.3} |
73. | MligTC455_26486 | 23 | 0.48 | Mlig455_061161 | Neo: - Age: - |
1.896 | - | - | 0.977 | - | 0.919 | - | Mlig455_061161 {REF} {Length: 903} {RNA1310_57274} {RNA815_36012} | |
74. | MligTC455_40387 | 28 | 0.59 | Mlig455_019391 | Neo: - Age: Up-Down-Down |
1.894 | - | - | 0.988 | - | 0.906 | - | Mlig455_019391 {REF} {Length: 2094} {Pfam: Sushi repeat (SCR repeat) [PF00084.22, score=34.2]} {Smed: dd_Smed_v6_41498_0_1, dd_Smed_v6_41498_0_1, [Score=146, Expect=1e-37]} {RNA1310_29891} {RNA815_15562} | |
75. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 1.893 | - | - | 0.958 | - | 0.935 | - | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
76. | MligTC455_02622 | 18 | 0.38 | Mlig455_034646, Mlig455_062629 | Neo: - Age: - |
CACNG5 | 1.892 | - | - | - | 0.952 | 0.940 | - | Mlig455_034646 {REF} {Length: 1447} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} Mlig455_062629 {REF} {Length: 1628} {Pfam: PMP-22/EMP/MP20/Claudin tight junction [PF13903.8, score=49.4]; PMP-22/EMP/MP20/Claudin family [PF00822.22, score=36.5]} {Human: ENSG00000075429, CACNG5, calcium voltage-gated channel auxiliary subunit gamma 5, [Score=73.2, Expect=3e-14]} {Mouse: ENSMUSG00000040373, Cacng5, calcium channel, voltage-dependent, gamma subunit 5, [Score=72.4, Expect=4e-14]} {RNA1310_115007} {RNA815_41269} |
77. | MligTC455_20113 | 4626 | 96.37 | Mlig455_032728 | Neo: - Age: - Region-enriched R2: 7.104/0.00000 |
ADAMTS4 | 1.891 | - | - | - | 0.972 | 0.919 | - | Mlig455_032728 {REF} {Length: 1834} {Pfam: Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=34.1]; Metallo-peptidase family M12 [PF13688.8, score=30.1]} {Human: ENSG00000158859, ADAMTS4, ADAM metallopeptidase with thrombospondin type 1 motif 4, [Score=50.1, Expect=3e-06]; ENSG00000154734, ADAMTS1, ADAM metallopeptidase with thrombospondin type 1 motif 1, [Score=48.1, Expect=3e-06]} {Mouse: ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=50.1, Expect=2e-06]} {RNA1509_811} {RNA1310_18102.1} {RNA815_7066} |
78. | MligTC455_20114 | 4655 | 96.97 | Mlig455_032750 | Neo: - Age: - Region-enriched R2: 6.812/0.00000 |
ADAMTS7 | 1.89 | - | - | - | 0.973 | 0.917 | - | Mlig455_032750 {REF} {Length: 1794} {Pfam: Metallo-peptidase family M12 [PF13688.8, score=51.5]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=44.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=39.8]; Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=37.0]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=26.8]; ADAM cysteine-rich domain [PF17771.3, score=26.3]; Astacin (Peptidase family M12A) [PF01400.26, score=18.3]} {Human: ENSG00000136378, ADAMTS7, ADAM metallopeptidase with thrombospondin type 1 motif 7, [Score=72.4, Expect=1e-12]; ENSG00000134917, ADAMTS8, ADAM metallopeptidase with thrombospondin type 1 motif 8, [Score=72.0, Expect=1e-12]} {Mouse: ENSMUSG00000058145, Adamts17, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 17, [Score=70.5, Expect=3e-12]; ENSMUSG00000031994, Adamts8, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 8, [Score=70.1, Expect=3e-12]; ENSMUSG00000046169, Adamts6, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 6, [Score=69.7, Expect=4e-12]; ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=68.2, Expect=1e-11]; ENSMUSG00000006403, Adamts4, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4, [Score=67.4, Expect=2e-11]} {Dmel: FBgn0029791, CG4096, [Score=74.3, Expect=1e-13]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [Score=58.5, Expect=6e-09]} {RNA1509_811} {RNA1310_18102.1, RNA1509_811} {RNA1509_811, RNA815_7066} |
79. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
1.889 | - | - | - | 0.964 | 0.925 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
80. | MligTC455_39222 | 213 | 4.44 | Mlig455_064653, Mlig455_064686 | Neo: - Age: - Region-enriched R2: 4.317/0.00597 |
1.879 | - | - | 0.984 | - | 0.895 | - | Mlig455_064653 {REF} {Length: 2836} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.9, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=7e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_56255} {RNA1310_13407} {RNA815_38407} Mlig455_064686 {REF} {Length: 3820} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.8]} {Mouse: ENSMUSG00000039079, Trhr2, thyrotropin releasing hormone receptor 2, [Score=58.5, Expect=6e-09]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [Score=73.6, Expect=8e-14]} {Celegans: WBGene00008885, F16C3.1, [Score=51.2, Expect=8e-07]} {Smed: dd_Smed_v6_13282_0_1, dd_Smed_v6_13282_0_1, [RH, Score=219, Expect=1e-66]} {RNA1509_50956} {RNA1310_13407} {RNA815_38407} |
|
81. | MligTC455_33636 | 175 | 3.64 | Mlig455_027209, Mlig455_050659 | Neo: - Age: logFC(26M/2M)=-0.416 Region-enriched R2: 3.904/0.00709 |
CHRNA10 | 1.878 | - | - | - | 0.977 | 0.901 | - | Mlig455_027209 {REF} {Length: 1614} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=99.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=74.0]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=152, Expect=1e-40]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=150, Expect=8e-40]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=149, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=148, Expect=6e-39]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=150, Expect=3e-40]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=150, Expect=5e-40]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=5e-38]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=133, Expect=1e-33]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=142, Expect=3e-37]} {RNA1310_19147.1} {RNA815_8553.1} Mlig455_050659 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=93.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=69.9]} {Human: ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=148, Expect=2e-39]; ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=144, Expect=1e-37]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=141, Expect=1e-36]} {Mouse: ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=148, Expect=1e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=141, Expect=9e-37]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=134, Expect=4e-34]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=144, Expect=7e-38]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=141, Expect=6e-37]} {RNA1310_19147.1} {RNA815_8553.1} |
82. | MligTC455_50362 | 295 | 6.16 | Mlig455_012011 | Neo: - Age: logFC(26M/2M)=1.080 Region-enriched R2: 3.396/0.00236 |
1.878 | - | - | - | 0.918 | 0.960 | - | Mlig455_012011 {REF} {Length: 947} {RNA1509_58656} {RNA1310_57201.1} {RNA815_30531.1} | |
83. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
1.877 | - | - | - | 1.000 | 0.877 | - | Mlig455_045246 {REF} {Length: 719} | |
84. | MligTC455_40011 | 150 | 3.12 | Mlig455_004436, Mlig455_004448 | Neo: - |
1.877 | - | - | - | 0.922 | 0.955 | - | Mlig455_004436 {REF} {Length: 595} {RNA1310_81676} Mlig455_004448 {REF} {Length: 1192} {RNA1310_81676} |
|
85. | MligTC455_45414 | 4030 | 83.95 | Mlig455_045096 | Neo: - Age: Down-Down-Up Region-specific R2: 2.245 Region-enriched R2: 1.386/0.00025 Regeneration-depleted TP: -1.938 |
1.877 | - | - | - | 0.926 | 0.951 | - | Mlig455_045096 {REF} {Length: 1427} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1310_24092, RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192} {RNA1509_17049, RNA1509_18052, RNA1509_29416, RNA1509_54192, RNA815_369.1} | |
86. | MligTC455_48760 | 15 | 0.31 | Mlig455_009006 | Neo: - Age: - |
SULT1A1 | 1.877 | - | - | - | 0.962 | 0.915 | - | Mlig455_009006 {REF} {Length: 1306} {Pfam: Sulfotransferase domain [PF00685.29, score=204.1]; Sulfotransferase family [PF13469.8, score=33.6]} {Human: ENSG00000196502, SULT1A1, sulfotransferase family 1A member 1, [RH, Score=162, Expect=4e-47]} {Mouse: ENSMUSG00000029269, Sult1b1, sulfotransferase family 1B, member 1, [RH, Score=167, Expect=8e-49]} {Dmel: FBgn0037665, St2, Sulfotransferase 2, [Score=131, Expect=4e-35]} {Celegans: WBGene00013748, ssu-1, Suppressor of Stomatin mutant Uncoordination, [Score=108, Expect=2e-26]} {Smed: dd_Smed_v6_34919_0_1, dd_Smed_v6_34919_0_1, [RH, Score=276, Expect=2e-91]} {RNA1310_95833} |
87. | MligTC455_52726 | 213 | 4.44 | Mlig455_032119 | Neo: - Age: - Region-enriched R2: 4.573/0.00005 |
1.876 | - | - | - | 0.923 | 0.953 | - | Mlig455_032119 {REF} {Length: 2626} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=61.9]; Capsular polysaccharide synthesis protein [PF05704.14, score=21.0]} {Smed: dd_Smed_v6_6819_0_1, dd_Smed_v6_6819_0_1, [Score=137, Expect=2e-37]} {RNA1509_41314} {RNA1310_26265} {RNA815_9794.1} | |
88. | MligTC455_15996 | 396 | 8.26 | Mlig455_064976, Mlig455_066809 | Neo: - Age: - |
ARHGEF17 | 1.873 | - | - | - | 0.912 | 0.961 | - | Mlig455_064976 {REF} {Length: 4968} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=136.4]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [Score=233, Expect=6e-61]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [Score=239, Expect=3e-63]} {Dmel: FBgn0262562, CG43102, [RH, Score=520, Expect=4e-156]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [RH, Score=240, Expect=2e-64]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=713, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_14497} Mlig455_066809 {REF} {Length: 5061} {Pfam: WD40 repeated domain [PF19056.2, score=146.7]; RhoGEF domain [PF00621.22, score=125.9]} {Human: ENSG00000110237, ARHGEF17, Rho guanine nucleotide exchange factor 17, [RH, Score=266, Expect=2e-71]} {Mouse: ENSMUSG00000032875, Arhgef17, Rho guanine nucleotide exchange factor (GEF) 17, [RH, Score=264, Expect=1e-70]} {Dmel: FBgn0262562, CG43102, [RH, Score=503, Expect=8e-150]} {Celegans: WBGene00019832, osg-1, Rho guanine nucleotide exchange factor osg-1, [Score=224, Expect=3e-59]} {Smed: dd_Smed_v6_2922_0_1, dd_Smed_v6_2922_0_1, [RH, Score=691, Expect=0.0]} {RNA1509_36394} {RNA1310_6117.1} {RNA815_23184} |
89. | MligTC455_25915 | 4499 | 93.72 | Mlig455_005297 | Neo: - Age: - Region-enriched R2: 1.495/0.00336 Regeneration-downregulated BL: -1.833 Regeneration-depleted BL: -1.833 |
CPE | 1.871 | - | - | - | 0.918 | 0.953 | - | Mlig455_005297 {REF} {Length: 3239} {Pfam: Zinc carboxypeptidase [PF00246.26, score=188.0]; Carboxypeptidase regulatory-like domain [PF13620.8, score=23.3]} {Human: ENSG00000109472, CPE, carboxypeptidase E, [Score=322, Expect=8e-105]} {Mouse: ENSMUSG00000037852, Cpe, carboxypeptidase E, [Score=318, Expect=1e-103]} {Dmel: FBgn0004648, svr, silver, [Score=225, Expect=2e-68]} {Celegans: WBGene00001189, egl-21, Carboxypeptidase E, [RH, Score=333, Expect=5e-110]} {Smed: dd_Smed_v6_3059_0_1, dd_Smed_v6_3059_0_1, [RH, Score=384, Expect=7e-130]} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1310_4621.1, RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908} {RNA1509_1158, RNA1509_34474, RNA1509_41810, RNA1509_58201, RNA1509_8908, RNA815_1336.1} |
90. | MligTC455_53413 | 249 | 5.2 | Mlig455_035022 | Neo: - Age: - Region-specific R2: 4.451 Region-enriched R2: 3.023/0.00460 |
RP1 | 1.871 | - | - | - | 0.952 | 0.919 | - | Mlig455_035022 {REF} {Length: 5065} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_57003} {RNA1310_2710} {RNA815_13802.1} |
91. | MligTC455_51176 | 71 | 1.48 | Mlig455_024765 | Neo: - Age: - |
SAXO1 | 1.869 | - | - | 0.988 | - | 0.881 | - | Mlig455_024765 {REF} {Length: 1803} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.5, Expect=9e-06]} {Smed: dd_Smed_v6_5551_0_1, dd_Smed_v6_5551_0_1, [Score=55.5, Expect=2e-08]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
92. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.868 | - | - | - | 0.971 | 0.897 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
93. | MligTC455_46173 | 63 | 1.3 | Mlig455_032091 | Neo: Irradiation Age: Up-Down-Up |
SRR | 1.865 | - | - | - | 0.908 | 0.957 | - | Mlig455_032091 {REF} {Length: 2590} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=208.5]; ACT domain [PF01842.27, score=19.8]} {Human: ENSG00000167720, SRR, serine racemase, [Score=129, Expect=2e-32]} {Mouse: ENSMUSG00000001323, Srr, serine racemase, [Score=105, Expect=4e-24]} {Dmel: FBgn0037684, CG8129, [Score=373, Expect=5e-123]} {Celegans: WBGene00010456, K01C8.1, [Score=407, Expect=5e-136]} {Smed: dd_Smed_v6_6737_0_1, dd_Smed_v6_6737_0_1, [Score=474, Expect=7e-163]} {RNA1509_48789} {RNA1310_15074} {RNA815_9364} |
94. | MligTC455_51536 | 78 | 1.62 | Mlig455_040699 | Neo: - Age: - |
1.863 | - | - | 0.907 | - | 0.956 | - | Mlig455_040699 {REF} {Length: 2015} {RNA1310_34295.1} {RNA815_22630} | |
95. | MligTC455_24926 | 47 | 0.99 | Mlig455_039672 | Neo: - Age: - |
1.859 | - | - | 0.951 | 0.908 | - | - | Mlig455_039672 {REF} {Length: 731} {RNA1310_113489} | |
96. | MligTC455_10786 | 15 | 0.32 | Mlig455_018164 | Neo: - Age: - |
1.856 | - | - | 0.998 | 0.858 | - | - | Mlig455_018164 {REF} {Length: 1819} {Pfam: F5/8 type C domain [PF00754.27, score=24.0]} {Smed: dd_Smed_v6_15258_0_1, dd_Smed_v6_15258_0_1, [RH, Score=57.8, Expect=5e-10]} {RNA1310_114361} | |
97. | MligTC455_21291 | 27 | 0.57 | Mlig455_009651 | Neo: - Age: - |
1.856 | - | - | 0.984 | - | 0.872 | - | Mlig455_009651 {REF} {Length: 3534} {RNA1310_43941} {RNA815_61115} | |
98. | MligTC455_15726 | 270 | 5.63 | Mlig455_031204 | Neo: - Age: - Region-enriched R2: 6.820/0.00015 |
ADAMTS18 | 1.849 | - | - | - | 0.994 | 0.855 | - | Mlig455_031204 {REF} {Length: 2405} {Pfam: Reprolysin (M12B) family zinc metalloprotease [PF01421.21, score=77.6]; Metallo-peptidase family M12 [PF13688.8, score=52.5]; Metallo-peptidase family M12B Reprolysin-like [PF13583.8, score=45.6]; Metallo-peptidase family M12B Reprolysin-like [PF13582.8, score=41.4]; ADAM cysteine-rich domain [PF17771.3, score=40.0]; Metallo-peptidase family M12B Reprolysin-like [PF13574.8, score=30.9]; Astacin (Peptidase family M12A) [PF01400.26, score=19.3]} {Human: ENSG00000140873, ADAMTS18, ADAM metallopeptidase with thrombospondin type 1 motif 18, [Score=90.9, Expect=1e-18]} {Mouse: ENSMUSG00000049538, Adamts16, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 16, [Score=90.1, Expect=1e-18]; ENSMUSG00000053399, Adamts18, a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 18, [Score=89.7, Expect=2e-18]} {Dmel: FBgn0034903, sona, sol narae, [RH, Score=114, Expect=7e-27]} {Celegans: WBGene00003248, mig-17, ADAM family mig-17, [RH, Score=100, Expect=2e-22]} {RNA1509_42775} {RNA1310_19585.1, RNA1509_42775} {RNA1509_42775, RNA815_17997} |
99. | MligTC455_47393 | 241 | 5.03 | Mlig455_008718, Mlig455_063579 | Neo: - Age: Down-Up-Down Region-enriched R2: 3.683/0.00849 |
CALM2 | 1.849 | - | - | - | 0.859 | 0.990 | - | Mlig455_008718 {REF} {Length: 1727} {Pfam: EF hand [PF00036.34, score=99.3]; EF-hand domain pair [PF13499.8, score=95.1]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13833.8, score=76.8]; EF hand [PF13202.8, score=75.3]; EF-hand domain [PF14658.8, score=46.0]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.9]; EF-hand domain [PF08976.13, score=23.4]; Uncharacterised protein family (UPF0154) [PF03672.15, score=18.7]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=108, Expect=4e-30]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=4e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=4e-30]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-30]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=108, Expect=2e-30]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=1e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-30]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-30]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=114, Expect=8e-33]} {RNA1310_33847.1} {RNA815_17211} Mlig455_063579 {REF} {Length: 2562} {Pfam: EF hand [PF00036.34, score=95.8]; EF-hand domain pair [PF13499.8, score=92.8]; EF-hand domain [PF13405.8, score=82.9]; EF-hand domain pair [PF13833.8, score=74.4]; EF hand [PF13202.8, score=72.2]; EF-hand domain [PF14658.8, score=43.8]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=38.5]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=25.6]; EF-hand domain [PF08976.13, score=21.4]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=111, Expect=7e-30]; ENSG00000198668, CALM1, calmodulin 1, [Score=108, Expect=3e-29]; ENSG00000160014, CALM3, calmodulin 3, [Score=108, Expect=3e-29]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=111, Expect=7e-30]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=108, Expect=2e-29]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=108, Expect=2e-29]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=106, Expect=9e-29]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=107, Expect=3e-29]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=107, Expect=2e-29]} {Smed: dd_Smed_v6_3441_0_1, dd_Smed_v6_3441_0_1, [Score=111, Expect=9e-31]} {RNA1310_12431.1} {RNA815_17211} |
100. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
1.848 | - | - | - | 0.889 | 0.959 | - | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} |